Home › Alpha-1 Antitrypsin Deficiency › South Carolina
Alpha-1 Antitrypsin Deficiency clinical trials in South Carolina
6 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in South Carolina.
Cities in South Carolina
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
- Clinical Study Center, Charleston
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT07227207A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07555483A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems
- University of South Carolina, Charleston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06512454Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Medical University of South Carolina, Charleston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated May 13, 2026 · NCT05677971A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
- Clinical Study Center, Charleston
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Mar 20, 2026 · NCT06389877A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
- Medical University of South Carolina, Charleston
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jul 22, 2025 · NCT06049082From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.